3 research outputs found

    Pemberian Ekstrak Curcuma Longa L. Meningkatkan Proliferasi Sel MEF yang dilakukan Scratch Test

    Get PDF
    Abstract: Proliferation Enhancement of Curcuma Longa L. Extract Treatment in MEF Cell Cultres that Treated by Scratch Test. Wound prevalence is still high and becomes a problem of healing process. Improper wounds management can cause wound healing disturbance, so that the healing process will be longer. For this reason, alternative medicine is required to shorten healing process and reduce medical costs. This study aims to determine the effect of Curcuma longa L. extract on enhancement of mouse embryonic fibroblast cell proliferation carried out in vitro scratch test with the research method using a laboratory in vitro experimental design and 24 hour observation. Observations were carried out for 24 hours with variations in Curcuma longa L. extract concentration 2.5 ppm, 5 ppm, 10 ppm, 25 ppm and 50 ppm. The results showed that Curcuma longa L extract was able to accelerate the proliferation of mouse embryonic fbroblast cells which scratch test. After 24 hours, the highest gap closure were observed in mouse embryonic fbroblast cell culture using dose of 2.5 ppm of Curcuma longa L. extract administration. At a dose of ≥10 ppm it does not show proliferation in embryonic fbroblast mouse cells but causes toxicity to cells. Abstrak: Pemberian Ekstrak Curcuma Longa L. Meningkatkan Proliferasi Sel MEF yang dilakukan Scratch Test. Prevalensi luka yang tinggi masih menjadi permasalahan tersendiri dalam proses penyembuhan. Penanganan luka yang tidak tepat dapat menyebabkan gangguan penyembuhan sehingga proses penyembuhan menjadi panjang. Untuk itu perlu alternatif pengobatan yang dapat mempersingkat penyembuhan dengan biaya pengobatan yang lebih murah. Penetian ini bertujuan mengetahui pengaruh pemberian ekstrak Curcuma longa L. terhadap peningkatan proliferasi sel mouse embryonic fibroblast yang dilakukan scratch test secara in vitro dengan metode penelitian menggunakan desain eksperimen in vitro laboratoris dan dilakukan pengamatan selama 24 jam. Variasi konsentrasi ekstrak Curcuma longa L menggunakan dosis 2.5 ppm, 5 ppm, 10 ppm, 25 ppm dan 50 ppm. Hasil pengamatan menunjukkan bahwa ekstrak Curcuma longa L. mampu mempercepat proliferasi sel mouse embryonic fbroblast yang dilakukan scratch test dengan dosis optimum 2.5 ppm. Pada dosis ≥10 ppm tidak menunjukkan proliferasi pada sel mouse embryonic fbroblast tetapi menyebabkan toksisitas pada sel

    The Effect of Progressive Muscle Relaxation Therapy on Anxiety in Hypertension Patients

    Get PDF
    Anxiety is a condition in which an individual experiences a concern about something that is not certain to happen, even some people experiencing anxiety but do not understand the specific cause of the anxiety source they feel. Anxiety problems, which are common in people, can be treated non-pharmacologically with deep muscle relaxation techniques, which do not require guided imagination or cause side effects in patients undergoing progressive muscle relaxation therapy. The objective of this study is to identify how progressive muscle relaxation techniques affected the anxiety levels of hypertension patients at the Kedaung Wetan Public Health Center. The study was conducted to determine if there was a difference in the level of anxiety experienced by hypertensive patients before and after receiving progressive muscle relaxation therapy. The design in this study employed a quasi-experimental pre-post-test with a control group with a progressive muscle relaxation therapy intervention. Result: there is a significant relationship between the period of occurrence of hypertension with anxiety experienced by respondents. Anxiety in hypertensive patients is more prevalent in those who are unfamiliar with hypertension. Thus, anxiety can arise from a sense of concern and fear of more serious complications which occur from the hypertension they are experiencing. The experimental group who received treatment in the form of progressive muscle relaxation therapy had a lower level of anxiety than the control group at the Kedaung Wetan Public Health Center in Tangerang City, with a p-value of 0.000

    The Potential Antibacterial Effect of Papaya Leaf Extract (Carica papaya L) and Miana Leaf Extract (Coleus scutellarioides L) as Adjuvant Therapy for Rifampicin-Resistant Tuberculosis

    No full text
    The adhesion of Rifampicin-resistant TB to neutrophils plays an essential role in colonization. Several active compounds in papaya leaf and Miana leaf (Coleus scutellarioides L) are believed to regulate or prevent the formation of bacterial colonies. The purpose of this study was to determine the anti-bacterial effectiveness of extracts of papaya leaf (Carica Papaya L.) and Miana leaf (Coleus scutellarioides L) against bacterial isolates of Rifampicin-Resistant TB strain (RR). This research method is a in vitro laboratory experiment, and extracts of papaya leaf and Miana leaf (50, 25, 12,5%) were tested as anti-bacterial using the M-TB susceptibility test using the Proportion Method. The results showed the anti-bacterial ability of papaya leaf extract against bacterial isolates of the MTBC-Resistant Rifampicin strain at a concentration of 50% with a resistance percentage value of 0% so that it was included in the Sensitive category, but at a concentration of 25% the resistance percentage value was 42.86% % and a concentration of 12.5%, the percentage value of resistance is 42.86% so that it is included in the category of resistance (Resistant > 1% and Sensitive < 1%). The anti-bacterial ability of miana leaf extract against bacterial isolates of the MTBC-Resistant Rifampicin strain at a concentration of 50% with a resistance percentage value of 5.33%, at a concentration of 25%, with a resistance percentage value of 17.14%, and at a concentration of 12.5%, with a resistance percentage value of 100%, so all are included in the resistant category. The Conclusion 50% papaya leaf extract inhibits the formation of Rifampicin-resistant MTBC-resistant bacterial colonies, allowing its usage as a substitute ingredient in Rifampicin-resistant MTBC-resistant medications
    corecore